Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Celecoxib|DRUG: Placebo|DRUG: Cholecalciferol
Sponsor: Hartford Hospital
Collaborators: United States Department of Defense|University of North Dakota